As of April 2024 GlaxoSmithKline has a market cap of $83.98 Billion. This makes GlaxoSmithKline the world's 189th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $83.98 B | 10.15% |
2023 | $76.25 B | 6% |
2022 | $71.93 B | -34.07% |
2021 | $109.10 B | 18.9% |
2020 | $91.76 B | -21.15% |
2019 | $116.38 B | 23.9% |
2018 | $93.93 B | 6.6% |
2017 | $88.11 B | -6.48% |
2016 | $94.22 B | -4.88% |
2015 | $99.05 B | -4.91% |
2014 | $104.16 B | -19.26% |
2013 | $129.00 B | 21.97% |
2012 | $105.76 B | -8.18% |
2011 | $115.19 B | 13.05% |
2010 | $101.89 B | -7.08% |
2009 | $109.65 B | 13.45% |
2008 | $96.66 B | -30.35% |
2007 | $138.78 B | -8.6% |
2006 | $151.83 B | 3.03% |
2005 | $147.36 B | 4.74% |
2004 | $140.69 B | 6.84% |
2003 | $131.68 B | 16.71% |
2002 | $112.83 B | -26.62% |
2001 | $153.76 B |
On Apr 28th, 2024 the market cap of GlaxoSmithKline was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Novartis NVS | $200.09 B | 138.24% | ๐จ๐ญ Switzerland |
Pfizer PFE | $143.82 B | 71.25% | ๐บ๐ธ USA |
Sanofi SNY | $122.65 B | 46.03% | ๐ซ๐ท France |
Merck MRK | $332.33 B | 295.69% | ๐บ๐ธ USA |
AstraZeneca AZN | $233.06 B | 177.49% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $15.64 B | -81.38% | ๐ฎ๐ฑ Israel |
Dynavax Technologies
DVAX | $1.46 B | -98.25% | ๐บ๐ธ USA |